Cart

0

Stocks

“JPMorgan: These 3 Stocks Could Spike at Least 70% From Current Levels”

Day One Biopharmaceuticals (DAWN)

Overall, there is broad agreement on Wall Street with Rama’s view, as indicated by the unanimous Strong Buy consensus rating, supported by 4 recent positive reviews. Shares in DAWN are selling for $20.11 and their $37.33 average price target implies a one-year upside potential of ~86%…

Altice USA, Inc. (ATUS)

What does the rest of the Street think? Looking at the consensus breakdown, opinions from other analysts are more spread out. 5 Buys, 3 Holds and 1 Sell add up to a Moderate Buy consensus. In addition, the $42.33 average price target indicates ~23% upside potential from current levels. ..

Similarweb (SMWB)

This new digital analytic stock has, in its short time on the public market, picked up 7 reviews from Wall Street’s analysts, with a breakdown of 5 to 2 Buy versus Hold giving the shares a Moderate Buy consensus rating. The stock is selling for $18.34 and the $27.67 average price target implies an upside of 52% for the upcoming year…”

https://finance.yahoo.com/news/jpmorgan-3-stocks-could-spike-201823204.html

Leave a Reply